Kezar Life Sciences Inc
(KZR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 12-2016 | |
| Operating Expenses | 5,086 | 0 | 2,192 | 1,881 | 0 |
| Operating Income | -5,086 | N/A | -2,192 | -1,881 | N/A |
| Other Income | 139 | 0 | 112 | 1 | 0 |
| Pre-tax Income | -4,947 | 0 | -2,080 | -1,880 | 0 |
| Net Income Continuous | -4,947 | N/A | -2,080 | -1,880 | N/A |
| Net Income | $-4,947 | $N/A | $-2,080 | $-1,880 | $N/A |
| EPS Basic Total Ops | -65.30 | N/A | -33.10 | -33.00 | N/A |
| EPS Basic Continuous Ops | -65.35 | N/A | -33.12 | -33.04 | N/A |
| EPS Diluted Total Ops | -65.30 | N/A | -33.10 | -33.00 | N/A |
| EPS Diluted Continuous Ops | -65.35 | N/A | -33.12 | -33.04 | N/A |
| EBITDA(a) | $-4,999 | $N/A | $-2,149 | $-1,881 | $N/A |